InsiderTrades.com logo
The "Smart Money" Is Ready for May 1st Are You?
From Stansberry Research   |   Ad
Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.
One Former Wall St. Trader Explains Why…
Paula B. Stafford net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Paula Stafford Biography and Net Worth

CEO of Novan

Paula Brown Stafford, MPH, is the President and Chief Executive Officer of Novan. Ms. Stafford also serves as Chairman of the Novan Board of Directors. Prior to joining Novan in March 2017, Ms. Stafford was President of Clinical Development at Quintiles (now IQVIA). In this role, Ms. Stafford was responsible for global clinical development services. While at Quintiles, Ms. Stafford was a member of the Executive Committee, the Technology Investment Committee, and a Board Observer. In addition to her role at Novan, Ms. Stafford is an adjunct professor in Public Health Leadership at the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. Ms. Stafford holds a Bachelor of Science and a Master of Public Health, both from the University of North Carolina at Chapel Hill, with a specialization in Biostatistics.

What is Paula B. Stafford's net worth?

The estimated net worth of Paula B. Stafford is at least $120.55 as of March 26th, 2021. Ms. Stafford owns 150,693 shares of Novan stock worth more than $121 as of April 25th. This net worth estimate does not reflect any other assets that Ms. Stafford may own. Additionally, Ms. Stafford receives an annual salary of $623,230.00 as CEO at Novan. Learn More about Paula B. Stafford's net worth.

How old is Paula B. Stafford?

Ms. Stafford is currently 58 years old. There are 2 older executives and no younger executives at Novan. Learn More on Paula B. Stafford's age.

What is Paula B. Stafford's salary?

As the CEO of Novan, Inc., Ms. Stafford earns $623,230.00 per year. Learn More on Paula B. Stafford's salary.

How do I contact Paula B. Stafford?

The corporate mailing address for Ms. Stafford and other Novan executives is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. Novan can also be reached via phone at (919) 485-8080 and via email at [email protected]. Learn More on Paula B. Stafford's contact information.

Has Paula B. Stafford been buying or selling shares of Novan?

Paula B. Stafford has not been actively trading shares of Novan within the last three months. Most recently, on Friday, March 26th, Paula B. Stafford bought 70,000 shares of Novan stock. The stock was acquired at an average cost of $1.43 per share, with a total value of $100,100.00. Following the completion of the transaction, the chief executive officer now directly owns 150,693 shares of the company's stock, valued at $215,490.99. Learn More on Paula B. Stafford's trading history.

Are insiders buying or selling shares of Novan?

During the last year, insiders at the sold shares 1 times. They sold a total of 11,553 shares worth more than $4,736.73. The most recent insider tranaction occured on June, 27th when Director Machelle Sanders sold 11,553 shares worth more than $4,736.73. Insiders at Novan own 1.3% of the company. Learn More about insider trades at Novan.

Information on this page was last updated on 6/27/2023.

Paula B. Stafford Insider Trading History at Novan

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/26/2021Buy70,000$1.43$100,100.00150,693View SEC Filing Icon  
5/20/2019Buy80,693$1.92$154,930.56693View SEC Filing Icon  
5/17/2019Buy693$1.49$1,032.57693View SEC Filing Icon  
See Full Table

Paula B. Stafford Buying and Selling Activity at Novan

This chart shows Paula B Stafford's buying and selling at Novan by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Novan Company Overview

Novan logo
Novan, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Durham, North Carolina.
Read More

Today's Range

Now: $0.00
Low: $0.00
High: $0.00

50 Day Range

MA: N/A

2 Week Range

Now: $0.00
Low: $0.08
High: $3.33

Volume

N/A

Average Volume

602,421 shs

Market Capitalization

$22,412.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
The "Smart Money" Is Ready for May 1st Are You?
From Stansberry Research   |   Ad
Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.
One Former Wall St. Trader Explains Why…